Background title lights.Background title stars.Title background molecules big.Title background molecules small.

News: Macrogen Europe appoints Dr Bongcho Kim as new CEO

Macrogen Europe, a leading provider of genomic sequencing services today announced the appointment of Dr Bongcho Kim as its new CEO. The appointment comes at a time of sustained growth for the company, which is benefitting from the rapidly expanding sequencing market thanks to a broad, innovative portfolio of genomic sequencing services.

 

Dr Kim joins Macrogen Europe BV after a successful career at Macrogen Inc in Seoul, South Korea. He joined Macrogen Inc in 2013 as a general manager for next generation sequencing (NGS) overseas sales, before being promoted to director and later vice president. Most recently, Dr Kim served as the managing director for the company’s technology and innovation division. Dr Kim holds a PhD in pathology from Seoul National University.

 

To support Macrogen Europe’s position as a comprehensive genomics service provider, expansion of its sequencing capabilities for emerging applications will be a key focus for the incoming CEO. This expansion includes the company’s bioinformatics offering, which has seen increased demand as scientists look for an end-to-end service that helps to reduce workloads and delivers faster analyses and interpretations of sequencing results.

 

“Being able to offer a complete solution for the latest applications will be an important driver for growth in the coming years,” said Dr Kim. “Expanding our capabilities for both sequencing and bioinformatics analysis in Amsterdam demonstrates to our customers that we remain a leading provider for cutting-edge genomics research with the high data quality and short turnaround times they have come to expect from us. These same characteristics will also help us expand into new markets as part of our long-term strategy for growth.”

 

Macrogen has over 20 years’ experience of providing high-quality genomic sequencing services. In 2008, it opened its European branch office in Amsterdam, which in 2017 became a subsidiary: Macrogen Europe BV. Using the latest technology from industry-leading suppliers such as Illumina, Pacific Biosciences and Themo Fisher Scientific, Macrogen delivers fast, accurate results to researchers and industry professionals across the EMEA region.